Low-dose aspirin does not lower the risk of colorectal cancer in patients with type 2 diabetes taking metformin.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Low-dose aspirin and metformin have been individually associated with a reduced risk of cancer. Whether their concurrent use in adults with type 2 diabetes mellitus (T2DM) is associated with a reduced risk of colorectal cancer (CRC) is unclear.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): J Intern Med

Title: Journal of internal medicine

Publisher: Wiley

ISSN (Electronic): 1365-2796

ISSN (Print): 0954-6820

Publication date (Electronic): Mar 2023

Volume: 293

Issue: 3

Affiliations

[1 ] Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong.

[2 ] Faculty of Medicine, Umm Alqura University, Mecca, Saudi Arabia.

[3 ] School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.

[4 ] Department of Family Medicine and Primary Care, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong.

[5 ] Laboratory of Data Discovery for Health (D24H), Hong Kong Science and Technology Park, Sha Tin, Hong Kong.

[6 ] Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, Hong Kong.

[7 ] Department of Medicine, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.

[8 ] Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, Hong Kong.

[9 ] Research Department of Practice and Policy, UCL School of Pharmacy, London, UK.

Article

DOI: 10.1111/joim.13590

PubMed ID: 36382924

SO-VID: e80d793a-9fe7-46dc-a287-33a20ed95517

History

Keywords: type 2 diabetes mellitus,colorectal cancer,metformin,cohort study,aspirin

Data availability:

Keywords: type 2 diabetes mellitus, colorectal cancer, metformin, cohort study, aspirin

Low-dose aspirin does not lower the risk of colorectal cancer in patients with type 2 diabetes taking metformin.

Read this article at

Abstract

Related collections

Karger: Oncology

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Similar content 145

Cited by 2